Yang Mingyi, Su Yani, Xu Ke, Wen Pengfei, Guo Jianbin, Yang Zhi, Liu Lin, Xu Peng
Department of Joint Surgery, HongHui Hospital, Xi'an Jiaotong University, 710054, Xi'an, Shaanxi, China.
Wien Klin Wochenschr. 2025 May;137(9-10):279-290. doi: 10.1007/s00508-024-02386-6. Epub 2024 Jun 20.
To investigate the genetic level causal association among hyperthyroidism, hypothyroidism, and rheumatoid arthritis (RA).
We utilized the genome-wide association studies (GWAS) summary data for exposure (hyperthyroidism and hypothyroidism) and outcome (RA) from the IEU OpenGWAS database. We used two different sets of data (test cohort and validation cohort) for causal assessment of exposure and outcome. To establish a causal relationship between these conditions, we conducted a two-sample Mendelian randomization (MR) analysis. Subsequently, we evaluated the MR analysis results for heterogeneity, horizontal pleiotropy, and outliers, aiming to assess the validity and reliability of the findings. Moreover, we conducted additional analyses to examine the robustness of the MR results, including a "Leave one out" analysis and the MR robust adjusted profile score (MR-RAPS) method, ensuring the robustness and adherence to normal distribution assumptions.
The findings from the test cohort indicated that hyperthyroidism did not exhibit a genetic causal association with RA (P = 0.702, odds ratio [OR] 95% confidence interval [CI] = 1.021 [0.918-1.135]). Conversely, hypothyroidism displayed a positive genetic causal relationship with RA (P < 0.001, OR 95% CI = 1.239 [1.140-1.347]). The analysis results of the validation cohort are consistent with those of the test cohort. Notably, our MR analysis results demonstrated no evidence of heterogeneity, horizontal pleiotropy, or outliers. Furthermore, our MR analysis results remained unaffected by any single nucleotide polymorphism (SNP) and exhibited a normal distribution.
The results of this study showed that hypothyroidism was positively correlated with RA, while hyperthyroidism was not causally correlated with RA. Hypothyroidism may as a risk factor of RA should be paid attention to in clinical work. Future studies are needed to further confirm this finding.
研究甲状腺功能亢进症、甲状腺功能减退症和类风湿关节炎(RA)之间在基因水平上的因果关联。
我们利用了IEU OpenGWAS数据库中关于暴露因素(甲状腺功能亢进症和甲状腺功能减退症)和结局(RA)的全基因组关联研究(GWAS)汇总数据。我们使用两组不同的数据(测试队列和验证队列)对暴露因素和结局进行因果评估。为了确定这些病症之间的因果关系,我们进行了两样本孟德尔随机化(MR)分析。随后,我们评估了MR分析结果的异质性、水平多效性和异常值,旨在评估研究结果的有效性和可靠性。此外,我们进行了额外的分析以检验MR结果的稳健性,包括“留一法”分析和MR稳健调整轮廓评分(MR-RAPS)方法,确保结果的稳健性并符合正态分布假设。
测试队列的研究结果表明,甲状腺功能亢进症与RA不存在基因因果关联(P = 0.702,优势比[OR] 95%置信区间[CI] = 1.021 [0.918 - 1.135])。相反,甲状腺功能减退症与RA呈现正基因因果关系(P < 0.001,OR 95% CI = 1.239 [1.140 - 1.347])。验证队列的分析结果与测试队列一致。值得注意的是,我们的MR分析结果未显示异质性、水平多效性或异常值的证据。此外,我们的MR分析结果不受任何单核苷酸多态性(SNP)的影响,且呈现正态分布。
本研究结果表明,甲状腺功能减退症与RA呈正相关,而甲状腺功能亢进症与RA无因果关联。甲状腺功能减退症可能作为RA的一个危险因素,在临床工作中应予以关注。未来需要进一步研究以证实这一发现。